Impaired liver function attenuates liver regeneration and hypertrophy after portal vein embolization

Table 2 Patient characteristics and hypertrophic rate in 13 patients who underwent portal vein embolization

		n	Hypertrophic rate (%)1	P
Age (mean)	50–80 (65)			P = 0.845
Sex (male/female)		10/3	30.5/40.1	P = 0.612
Background liver disease (yes/no)		6/7	23.1/40.1	P = 0.087
Platelet count (/mm3) ≥ 100		12	30.5	P = 0.593
< 100		1	40.1
Total bilirubin (mg/dL) ≥ 1.5		4	19.7	P < 0.05
< 1.5		9	40.0
ICG-R15 (%) ≥ 20		2	12.0	P < 0.05
< 20		11	34.2
Diabetes mellitus (yes/no)		3/10	32.2/31.4	P = 1.000
Preoperative chemotherapy (yes/no)		3/10	40.1/26.8	P = 0.237

¹Median. ICG-R15: Indocyanine green retention rate at 15 min.